Results

Total Results: 7,590 records

Showing results for "how to do a case study".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - We do not anticipate excluding observational studies assessing harms. … For all Key Questions, we excluded uncontrolled observational studies, case series, and case reports … Peer reviewers do not participate in writing or editing of the final report or other products. … Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment … studies, registries and case reports.
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
    October 23, 2018 - staff reported no adverse events; however, it is not clear whether adverse events were prespecified or howHow well do interventions reduce exposure to IPV, physical or mental morbidity, or mortality among screen-detected … RCTs (n = 1031) reported that no harms were associated with the intervention but did not comment on how … The opinions expressed in this document are those of the authors and do not reflect the official position … Domestic violence: how to screen & intervene. RN . 2000;63(12):52-56. 48.
  3. meps.ahrq.gov/data_files/publications/mr3/mr3.pdf
    September 01, 1998 - , with information on how to obtain these resources. … (For operational details on how this was accomplished, see information in this report on the Round 1 … A fictitious example of how a Place Roster might look on the interviewer’s laptop at the end of the Round … DO NEXT. … As a result, interviewers do not have to key the name, form, and strength of drugs on the preloaded list
  4. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … However, they believe that questions remain about how much additional benefit this intervention would … However, a couple of experts raised questions about the role of the patient’s physician and how he … However, they believe that questions remain about how much additional benefit this intervention offers … Experts were divided about how this intervention would affect patient management and treatment models
  5. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
    April 01, 2020 - Additionally, many individuals clinically diagnosed with CATD do not meet neuropathologic (gold standard … Therefore, we also need better understanding of how accurate pre- mortem brain imaging and cerebrospinal … Research should better clarify how biomarker accuracy varies as a function of the time between biomarker … collection and autopsy, to inform how changes in biomarkers and brain neuropathology over time affect … Studies should report information about participant clinical diagnosis to make it clear how often clinical
  6. digital.ahrq.gov/sites/default/files/docs/citation/r21hs021769-anderson-final-report-2016.pdf
    January 01, 2016 - supported by grant number R21 HS21769-02 and its contents are solely the responsibility of the authors and do … four days prior to each scheduled clinical visit; and (3) monthly, if a patient did not have a clinical … They were also asked if they had filled their antidepressant prescription, and if so, how many doses … interact with the participating practices on a regular basis and do in-person recruitment and consenting … their antidepressant and if so, how many doses they had missed in the past week.
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/gJQj_6nEHZ7XAhYPfhVR33
    January 01, 2016 - These average estimates do not reflect greater ex- tremes seen among outlier radiologists. … As a result, across studies a sizeable 13% to 19% of women (13–19) were reclassified from “nondense” … Moving from a “dense” to a “non- dense” breast categorization may result in different mandated communications … Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms .do? … negative screening mammogram in women found to have dense breasts, and how do these performance
  8. digital.ahrq.gov/sites/default/files/docs/citation/state-regional-demonstration-hit-in-final-report.pdf
    July 01, 2015 - If So, How? … If So, How? … If So, How? … If So, How? … If So, How?
  9. hcup-us.ahrq.gov/reports/statbriefs/sb27.jsp
    March 01, 2007 - Login Do Your own analysis Explore Expert Research & Limited … Symptoms of a TBI can range from mild to severe, depending on the extent of damage to the brain. … According to the Centers for Disease Control and Prevention (CDC), TBIs contribute to a substantial number … We also invite you to tell us how you are using this Statistical Brief and other HCUP data and tools, … and to share suggestions on how HCUP products might be enhanced to further meet your needs.
  10. digital.ahrq.gov/sites/default/files/docs/page/final-hit-enabled-quality-measurement-snapshot.pdf
    July 01, 2012 - • How to Move to Patient-Centricity in a Fragmented Health Delivery System – Although there is consensus … Benin AL, Fenick A, Herrin J, et al.. How good are the data? … It measures what patients are able to do and how they feel by asking questions. … • How do they hinder progress related to quality measurement enabled by health IT? … • How do stakeholders address known gaps/problem areas?
  11. digital.ahrq.gov/sites/default/files/docs/publication/final-hit-enabled-quality-measurement-snapshot.pdf
    July 01, 2012 - • How to Move to Patient-Centricity in a Fragmented Health Delivery System – Although there is consensus … Benin AL, Fenick A, Herrin J, et al.. How good are the data? … It measures what patients are able to do and how they feel by asking questions. … • How do they hinder progress related to quality measurement enabled by health IT? … • How do stakeholders address known gaps/problem areas?
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF The DEcIDE (Developing Evidence to Inform … document are those of the authors, who are responsible for its contents; the findings and conclusions doTo ensure a uniform 1-year eligibility period prior to filling the index APM prescription, all study … CV or OOH CV deaths by conventional APM vs. atypical APM use in patients with dementia (Table 4) doHow much are atypical antipsychotic agents being used, and do they reach the populations who need
  13. hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.jsp
    January 01, 2005 - For more information on how hospitals in the data set were mapped to hospitals as defined by the AHA, … Contents HOW TO USE THE NIS This section provides a brief synopsis of special considerations when … Some states do not require hospitals to report E codes in the range E870-E879 - "misadventures to patients … This site includes links to information on how to purchase and understand the HCUP databases, as well … Topics range from how to use the NIS for reporting trends, how to properly calculate variance estimates
  14. www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
    May 24, 2022 - How to implement this recommendation?   … Clinicians should use their clinical judgement to determine how to evaluate patients who have symptoms … assessment tools and screening interventions that include higher-risk groups, as well as more research on how … Any adaptations of these electronic documents and resources must include a disclaimer to this effect. … Eye care in the United States: do we deliver to high-risk people who can benefit most from it?
  15. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
    August 23, 2022 - without a history of known CVD and who do not have signs and symptoms of CVD. … These recommendations do not apply to adults with a low-density lipoprotein cholesterol (LDL-C) level … The USPSTF also recommended that clinicians may choose to offer a low- to moderate-dose statin to adults … No trials reported how benefits of statin therapy vary according to socioeconomic characteristics. 13 … In addition, the USPSTF wants to clarify that these recommendations do not pertain to adults with familial
  16. www.ahrq.gov/sites/default/files/2024-01/dresselhaus-report.pdf
    January 01, 2024 - Consenting subjects agreed to carry a palm handheld unit for a 1-week period. … Subjects were prompted by a handheld-generated audible alarm to initiate a survey. … However, they do permit some level of interpretive analysis, even with incomplete error data points. … We hope that an improved understanding of how these factors are influenced by workplace activity patterns … , as well as how psychosocial characteristics affect medication error events, can be used in future
  17. hcup-us.ahrq.gov/reports/methods/2009_02.pdf
    January 01, 2009 - interest and a denominator count of the population (within a hospital or geographic area) to which … Many hospitals do not code race and ethnicity completely. … know if and how quality of care varies for these different populations. … This document describes how state-level QIs by race/ethnicity and community income quartile were generated … We do not employ finite population correction factors in estimating standard errors.
  18. hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2019.jsp
    January 01, 2019 - This tutorial also describes how to verify that the data have loaded correctly. … Return to Introduction   HOW TO USE THE NEDS FOR DATA ANALYSIS This section provides a brief … It may be useful to compare diagnosis-specific ED visits that do not result in hospitalization to those … Some States do not require hospitals to report codes for "misadventures to patients during surgical and … the NEDS to produce data elements not available for a certain data year may do so by downloading the
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - how the new evidence impacts findings of the 2020 report. … How does effectiveness or comparative effectiveness vary depending on: (1) the specific type or cause … How do harms vary depending on: (1) the specific type or cause of pain, (2) patient demographics, (3 … document are those of the authors, who are responsible for its contents; the findings and conclusions doHow do harms vary depending on: (1) the specific type or cause of pain, (2) patient demographics, (3
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - , the review also evaluates how comparative effectiveness varies depending on HCV genotype, viral load … How does the comparative effectiveness of antiviral treatment for health outcomes vary according toHow does the comparative effectiveness of antiviral treatment for intermediate outcomes vary according … Do these harms differ according to patient subgroup characteristics, including HCV genotype, age, race … Low Key Question 3b Do these harms differ according to patient subgroup characteristics?